The invention discloses a pharmaceutical composition containing a
photosensitizer and an
autophagy inhibitor, each unit
dose of the pharmaceutical composition contains 1-100mg of a photosensitive
drug DTP and 6-600mg of an
autophagy inhibitor
chloroquine phosphate, and the unit
dose is the total amount of a pharmaceutical preparation used every day. The pharmaceutical composition containing the
photosensitizer and the
autophagy inhibitor is prepared by mixing 1-100mg of a photosensitive
drug DTP and 6-600mg of an autophagy inhibitor
chloroquine phosphate to prepare a liquid preparation for injection administration, such as freeze-dried
powder injection, injection, large and small infusion or intravenous drip. The invention also provides an application of a pharmaceutical composition taking the photosensitive
drug DTP and the autophagy inhibitor
chloroquine phosphate as active ingredients in preparation of antitumor drugs. The pharmaceutical composition taking the photosensitive drug DTP and the autophagy inhibitor
chloroquine phosphate as the active ingredients has a remarkable
treatment effect in the anti-tumor aspect, not only has a good
treatment effect on local tumors of prostatic
cancer, but also shows synergistic anti-tumor activity. Combined application of the
photodynamic therapy and the autophagy inhibitor is a research hot spot in the field of tumor treatment, and the research trend focuses on improvement of the
treatment effect and deep understanding of an interaction mechanism between the
photodynamic therapy and
cell autophagy, so that the
photodynamic therapy and the autophagy inhibitor can be more effectively applied to
clinical treatment.